Your session is about to expire
← Back to Search
Device
tDCS for Chronic Pain in Aging Workers
N/A
Recruiting
Led By Guillaume Leonard, PhD
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
To be more than 55 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, about 2 years
Awards & highlights
Study Summary
This trial will help determine if tDCS is an effective treatment for chronic pain in older workers, and if the traditional 5-session protocol is as effective as the enhanced 11-session protocol.
Who is the study for?
This trial is for individuals over 55 who suffer from chronic pain that affects their work. Participants must be currently employed. Those with epilepsy, metallic head implants, pacemakers, or cochlear implants cannot join due to risks associated with the treatment.Check my eligibility
What is being tested?
The study tests transcranial direct current stimulation (tDCS) as a method to reduce chronic pain in older workers. It compares two protocols: one with 5 sessions and an enhanced one with 11 sessions, aiming to see which is more effective for pain relief and work retention.See study design
What are the potential side effects?
Potential side effects of tDCS may include mild discomfort at the site of electrode placement, itching or tingling during the session, fatigue, headache, nausea or insomnia post-treatment. These are generally mild and temporary.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am older than 55 years.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, about 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, about 2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Anxiety
Central sensitization
Depression
+5 moreSecondary outcome measures
Intervention
Recruitment
Security
Trial Design
2Treatment groups
Experimental Treatment
Group I: Standard protocolExperimental Treatment1 Intervention
5 tDCS sessions in 1 week
Group II: Enhanced protocolExperimental Treatment1 Intervention
11 tDCS sessions devised in 4 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
transcranial direct current stimulation
2013
Completed Phase 3
~1430
Find a Location
Who is running the clinical trial?
Université de SherbrookeLead Sponsor
292 Previous Clinical Trials
69,417 Total Patients Enrolled
11 Trials studying Chronic Pain
1,124 Patients Enrolled for Chronic Pain
CISSS Abitibi-TémiscamingueUNKNOWN
Guillaume Leonard, PhDPrincipal InvestigatorUniversité de Sherbrooke
2 Previous Clinical Trials
78 Total Patients Enrolled
2 Trials studying Chronic Pain
78 Patients Enrolled for Chronic Pain
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My pain stops me from doing my job.I am older than 55 years.I have long-term pain.I don't have epilepsy, a metallic head implant, pacemaker, or cochlear implant.
Research Study Groups:
This trial has the following groups:- Group 1: Standard protocol
- Group 2: Enhanced protocol
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor currently recruiting participants?
"Yes, as indicated by the clinicaltrials.gov website, this research is currently enrolling participants. The initiative was initially publicised on May 15th 2022 and has been amended since then; now recruiting 24 patients at a single site."
Answered by AI
How many participants are being observed in this trial?
"Affirmative. Data available on clinicaltrials.gov verifies that this trial, initially posted on May 15th 2022, is currently recruiting participants. Specifically they are looking for 24 people to join from 1 medical centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger